tiprankstipranks
Jubilant Pharmova Limited (IN:JUBLPHARMA)
:JUBLPHARMA
India Market
JUBLPHARMA
Jubilant Pharmova Limited
RESEARCH TOOLSreports
Want to see IN:JUBLPHARMA full AI Analyst Report?

Jubilant Pharmova Limited (JUBLPHARMA) Ratios

2 Followers

Jubilant Pharmova Limited Ratios

IN:JUBLPHARMA's free cash flow for Q2 2026 was ₹0.32. For the 2026 fiscal year, IN:JUBLPHARMA's free cash flow was decreased by ₹ and operating cash flow was ₹0.12. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 1.62 1.62 1.65 2.05 2.12
Quick Ratio
 1.13 1.13 1.13 1.36 1.32
Cash Ratio
 0.50 0.50 0.50 0.50 0.57
Solvency Ratio
 0.10 0.10 0.17 0.06 0.04
Operating Cash Flow Ratio
 0.15 0.40 0.50 0.51 0.37
Short-Term Operating Cash Flow Coverage
 1.17 3.22 3.74 3.93 2.20
Net Current Asset Value
₹ -43.18B₹ -43.18B₹ -29.41B₹ -22.51B₹ -20.02B
Leverage Ratios
Debt-to-Assets Ratio
 0.23 0.23 0.21 0.32 0.33
Debt-to-Equity Ratio
 0.51 0.51 0.44 0.67 0.68
Debt-to-Capital Ratio
 0.34 0.34 0.30 0.40 0.41
Long-Term Debt-to-Capital Ratio
 0.30 0.30 0.26 0.37 0.37
Financial Leverage Ratio
 2.19 2.19 2.04 2.13 2.07
Debt Service Coverage Ratio
 1.94 1.98 1.71 1.34 1.13
Interest Coverage Ratio
 6.23 3.87 9.80 7.58 10.55
Debt to Market Cap
 0.21 0.25 0.17 0.37 0.77
Interest Debt Per Share
 241.96 241.50 187.08 248.12 242.85
Net Debt to EBITDA
 1.89 1.86 1.57 3.42 4.12
Profitability Margins
Gross Profit Margin
38.45%30.13%64.95%64.92%66.86%
EBIT Margin
9.71%9.90%11.11%7.80%5.97%
EBITDA Margin
14.96%15.22%14.48%11.84%10.29%
Operating Profit Margin
15.93%9.90%32.56%30.80%31.60%
Pretax Profit Margin
7.42%7.42%13.55%2.54%0.44%
Net Profit Margin
4.81%4.81%11.60%1.15%-0.97%
Continuous Operations Profit Margin
4.80%4.80%11.56%1.08%-1.03%
Net Income Per EBT
64.89%64.89%85.60%45.22%-219.42%
EBT Per EBIT
46.55%74.95%41.63%8.26%1.40%
Return on Assets (ROA)
2.57%2.57%6.58%0.67%-0.55%
Return on Equity (ROE)
6.09%5.62%13.42%1.42%-1.13%
Return on Capital Employed (ROCE)
10.16%6.31%22.24%21.37%21.15%
Return on Invested Capital (ROIC)
6.42%3.99%18.37%8.84%-47.59%
Return on Tangible Assets
3.49%3.49%9.21%0.96%-0.78%
Earnings Yield
2.54%3.08%5.76%0.85%-1.37%
Efficiency Ratios
Receivables Turnover
 7.73 7.73 8.10 5.36 5.98
Payables Turnover
 4.13 4.69 2.52 2.75 2.53
Inventory Turnover
 4.14 4.70 2.25 1.80 1.46
Fixed Asset Turnover
 1.20 1.20 1.40 1.82 1.87
Asset Turnover
 0.53 0.53 0.57 0.58 0.56
Working Capital Turnover Ratio
 5.63 5.55 4.26 3.37 3.22
Cash Conversion Cycle
 47.05 47.07 62.94 137.58 166.30
Days of Sales Outstanding
 47.24 47.24 45.03 68.12 61.06
Days of Inventory Outstanding
 88.20 77.70 162.54 202.39 249.25
Days of Payables Outstanding
 88.39 77.86 144.64 132.93 144.01
Operating Cycle
 135.44 124.93 207.58 270.51 310.31
Cash Flow Ratios
Operating Cash Flow Per Share
 23.33 63.93 67.50 61.23 41.51
Free Cash Flow Per Share
 -23.44 -27.53 -2.74 4.64 -9.66
CapEx Per Share
 46.77 91.46 70.24 56.59 51.18
Free Cash Flow to Operating Cash Flow
 -1.00 -0.43 -0.04 0.08 -0.23
Dividend Paid and CapEx Coverage Ratio
 0.45 0.66 0.90 0.99 0.74
Capital Expenditure Coverage Ratio
 0.50 0.70 0.96 1.08 0.81
Operating Cash Flow Coverage Ratio
 0.10 0.28 0.39 0.27 0.18
Operating Cash Flow to Sales Ratio
 0.04 0.12 0.15 0.14 0.11
Free Cash Flow Yield
-2.36%-3.37%-0.30%0.81%-3.47%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 39.29 32.46 17.35 118.23 -72.75
Price-to-Sales (P/S) Ratio
 1.89 1.56 2.01 1.36 0.71
Price-to-Book (P/B) Ratio
 2.21 1.82 2.33 1.68 0.82
Price-to-Free Cash Flow (P/FCF) Ratio
 -42.31 -29.66 -334.81 123.85 -28.86
Price-to-Operating Cash Flow Ratio
 42.44 12.77 13.58 9.38 6.72
Price-to-Earnings Growth (PEG) Ratio
 -0.75 -0.62 0.02 -0.52 0.63
Price-to-Fair Value
 2.21 1.82 2.33 1.68 0.82
Enterprise Value Multiple
 14.56 12.13 15.47 14.91 10.99
Enterprise Value
 180.30B 152.84B 162.07B 118.26B 71.01B
EV to EBITDA
 14.56 12.13 15.47 14.91 10.99
EV to Sales
 2.18 1.85 2.24 1.76 1.13
EV to Free Cash Flow
 -48.64 -35.04 -372.57 160.67 -46.17
EV to Operating Cash Flow
 48.86 15.09 15.12 12.18 10.75
Tangible Book Value Per Share
 189.25 188.89 163.76 120.64 126.43
Shareholders’ Equity Per Share
 448.50 447.64 393.82 342.53 339.26
Tax and Other Ratios
Effective Tax Rate
 0.35 0.35 0.15 0.57 3.33
Revenue Per Share
 523.54 522.54 455.50 422.52 394.71
Net Income Per Share
 25.20 25.15 52.85 4.86 -3.83
Tax Burden
 0.65 0.65 0.86 0.45 -2.19
Interest Burden
 0.76 0.75 1.22 0.33 0.07
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.23 0.20 0.32 0.33 0.35
Stock-Based Compensation to Revenue
 <0.01 0.00 <0.01 <0.01 <0.01
Income Quality
 0.64 2.54 1.28 12.60 23.78
Currency in INR